CSTL

Castle Biosciences Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↑ 7/10
  • Value↓ 2/10
Castle Biosciences sales and earnings growth
CSTL Growth
Good
  • Revenue Y/Y↓ -2.06%
  • EPS Y/Y↓ -180.00%
  • FCF Y/Y↓ -89.08%
Castle Biosciences gross and profit margin trends
CSTL Profitability
Fair
  • Gross margin ↑ 77.90%
  • EPS margin↓ -3.80%
  • ROIC 5Y↓ -12.30%
Castle Biosciences net debt vs free cash flow
CSTL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -86.0

Castle Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Diagnostics & Research stocks